Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 4
1971 1
1972 10
1973 8
1974 10
1975 13
1976 8
1977 14
1978 6
1979 14
1980 14
1981 22
1982 30
1983 24
1984 24
1985 30
1986 24
1987 25
1988 37
1989 33
1990 35
1991 40
1992 25
1993 26
1994 28
1995 24
1996 24
1997 28
1998 14
1999 12
2000 21
2001 25
2002 16
2003 22
2004 23
2005 26
2006 23
2007 22
2008 18
2009 20
2010 13
2011 29
2012 38
2013 21
2014 16
2015 22
2016 23
2017 26
2018 14
2019 8
2020 10
2021 15
2022 15
2023 5

Text availability

Article attribute

Article type

Publication date

Search Results

1,027 results

Results by year

Filters applied: . Clear all
Page 1
Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections.
Miller LG, Daum RS, Creech CB, Young D, Downing MD, Eells SJ, Pettibone S, Hoagland RJ, Chambers HF; DMID 07-0051 Team. Miller LG, et al. N Engl J Med. 2015 Mar 19;372(12):1093-103. doi: 10.1056/NEJMoa1403789. N Engl J Med. 2015. PMID: 25785967 Free PMC article. Clinical Trial.
Patients were randomly assigned in a 1:1 ratio to receive either clindamycin or trimethoprim-sulfamethoxazole (TMP-SMX) for 10 days. ...RESULTS: A total of 524 patients were enrolled (264 in the clindamycin group and 260 in the TMP-SMX group), including 155 children …
Patients were randomly assigned in a 1:1 ratio to receive either clindamycin or trimethoprim-sulfamethoxazole (TMP-SMX) for 10 days. …
Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug.
Stein Gold L, Baldwin H, Kircik LH, Weiss JS, Pariser DM, Callender V, Lain E, Gold M, Beer K, Draelos Z, Sadick N, Pillai R, Bhatt V, Tanghetti EA. Stein Gold L, et al. Am J Clin Dermatol. 2022 Jan;23(1):93-104. doi: 10.1007/s40257-021-00650-3. Epub 2021 Oct 21. Am J Clin Dermatol. 2022. PMID: 34674160 Free PMC article. Clinical Trial.
OBJECTIVES: We aimed to evaluate the efficacy and safety of triple-combination, fixed-dose topical clindamycin phosphate 1.2%/benzoyl peroxide (BPO) 3.1%/adapalene 0.15% (IDP-126) gel for the treatment of acne. METHODS: In a phase II, double-blind, multicenter, randomized, …
OBJECTIVES: We aimed to evaluate the efficacy and safety of triple-combination, fixed-dose topical clindamycin phosphate 1.2%/benzoyl …
Efficacy and Safety of Tazarotene 0.1% Plus Clindamycin 1% Gel Versus Adapalene 0.1% Plus Clindamycin 1% Gel in Facial Acne Vulgaris: A Randomized, Controlled Clinical Trial.
Maiti R, Sirka CS, Ashique Rahman MA, Srinivasan A, Parida S, Hota D. Maiti R, et al. Clin Drug Investig. 2017 Nov;37(11):1083-1091. doi: 10.1007/s40261-017-0568-2. Clin Drug Investig. 2017. PMID: 28913735 Clinical Trial.
OBJECTIVES: The present study was conducted to compare the efficacy and safety of tazarotene plus clindamycin against adapalene plus clindamycin in facial acne vulgaris. ...After randomization one group (n = 30) received tazarotene 0.1% plus clindamycin 1% ge …
OBJECTIVES: The present study was conducted to compare the efficacy and safety of tazarotene plus clindamycin against adapalene plus …
Efficacy and safety of a nano-emulsion gel formulation of adapalene 0.1% and clindamycin 1% combination in acne vulgaris: a randomized, open label, active-controlled, multicentric, phase IV clinical trial.
Prasad S, Mukhopadhyay A, Kubavat A, Kelkar A, Modi A, Swarnkar B, Bajaj B, Vedamurthy M, Sheikh S, Mittal R. Prasad S, et al. Indian J Dermatol Venereol Leprol. 2012 Jul-Aug;78(4):459-67. doi: 10.4103/0378-6323.98077. Indian J Dermatol Venereol Leprol. 2012. PMID: 22772617 Free article. Clinical Trial.
AIMS: To assess the comparative efficacy and safety of a nano-emulsion gel formulation of adapalene and clindamycin combination with its conventional formulation in the treatment of acne vulgaris of the face. ...CONCLUSIONS: The nano-emulsion gel formulation of adapalene a …
AIMS: To assess the comparative efficacy and safety of a nano-emulsion gel formulation of adapalene and clindamycin combination with …
A clinical trial comparing the safety and efficacy of a topical erythromycin-zinc formulation with a topical clindamycin formulation.
Schachner L, Pestana A, Kittles C. Schachner L, et al. J Am Acad Dermatol. 1990 Mar;22(3):489-95. doi: 10.1016/0190-9622(90)70069-t. J Am Acad Dermatol. 1990. PMID: 2138180 Free article. Clinical Trial.
One hundred three patients with acne vulgaris were randomly designated to receive either a topical formulation of erythromycin plus zinc or a topical solution of 1% clindamycin phosphate (Cleocin-T). The patients treated themselves twice daily and were examined at 3, 6, 9, …
One hundred three patients with acne vulgaris were randomly designated to receive either a topical formulation of erythromycin plus zinc or …
A comparison of dequalinium chloride vaginal tablets (Fluomizin®) and clindamycin vaginal cream in the treatment of bacterial vaginosis: a single-blind, randomized clinical trial of efficacy and safety.
Weissenbacher ER, Donders G, Unzeitig V, Martinez de Tejada B, Gerber S, Halaška M, Špaček J; Fluomizin Study Group. Weissenbacher ER, et al. Gynecol Obstet Invest. 2012;73(1):8-15. doi: 10.1159/000332398. Epub 2011 Dec 24. Gynecol Obstet Invest. 2012. PMID: 22205034 Free article. Clinical Trial.
AIMS: To investigate if vaginal application of dequalinium chloride (DQC, Fluomizin) is as effective as vaginal clindamycin (CLM) in the treatment of bacterial vaginosis (BV). METHODS: This was a multinational, multicenter, single-blind, randomized trial in 15 centers, inc …
AIMS: To investigate if vaginal application of dequalinium chloride (DQC, Fluomizin) is as effective as vaginal clindamycin (CLM) in …
Safety, Tolerability, and Pharmacokinetics of Tazarotene Clindamycin Cream: A Single-Dose, 3-Period Crossover Study.
Li L, Zhang XF, Yang GP, Huang J, Yang XY, Ye L, Guo C, Yang S, Wang XM. Li L, et al. Clin Pharmacol Drug Dev. 2021 Jun;10(6):598-606. doi: 10.1002/cpdd.890. Epub 2020 Nov 25. Clin Pharmacol Drug Dev. 2021. PMID: 33241616 Clinical Trial.
The current study compared the safety, tolerability, and pharmacokinetics of the new compound pharmaceutical preparation tazarotene clindamycin cream, and 2 single pharmaceutical preparations, tazarotene cream and clindamycin phosphate gel. ...The incidences of skin …
The current study compared the safety, tolerability, and pharmacokinetics of the new compound pharmaceutical preparation tazarotene clind …
Comparative Trial of Silver Nanoparticle Gel and 1% Clindamycin Gel when Use in Combination with 2.5% Benzoyl Peroxide in Patients with Moderate Acne Vulgaris.
Jurairattanaporn N, Chalermchai T, Ophaswongse S, Udompataikul M. Jurairattanaporn N, et al. J Med Assoc Thai. 2017 Jan;100(1):78-85. J Med Assoc Thai. 2017. PMID: 29911775 Clinical Trial.
OBJECTIVE: To compare the efficacy and safety between silver nanoparticle gel and 1% clindamycin gel both combine with 2.5% benzoyl peroxide for the treatment of moderate severity of acne vulgaris. ...RESULTS: After 8 weeks of follow-up period, the average mean percent cha …
OBJECTIVE: To compare the efficacy and safety between silver nanoparticle gel and 1% clindamycin gel both combine with 2.5% benzoyl p …
LAight® Therapy Significantly Enhances Treatment Efficacy of 16 Weeks of Topical Clindamycin Solution in Hurley I and II Hidradenitis Suppurativa: Results from Period A of RELIEVE, a Multicenter Randomized, Controlled Trial.
Schultheis M, Staubach P, Nikolakis G, Grabbe S, Ruckes C, von Stebut E, Kirschner U, Matusiak Ł, Szepietowski JC. Schultheis M, et al. Dermatology. 2022;238(3):476-486. doi: 10.1159/000518540. Epub 2021 Sep 14. Dermatology. 2022. PMID: 34535610 Clinical Trial.
After 16 weeks of treatment, the IHS4 of the group treated with the combination of LAight therapy and topical clindamycin 1% solution was -7.2 6.7 (-60.0%), which was significantly higher in magnitude than the IHS4 in the group treated with clindamycin 1% solution a …
After 16 weeks of treatment, the IHS4 of the group treated with the combination of LAight therapy and topical clindamycin 1% solution …
1,027 results